# Halobetasol Propionate

NDC: 45802-131
Generic name: Halobetasol Propionate
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: OINTMENT
Routes: TOPICAL
Marketing started: 20090205

FDA application: ANDA076872

## Active ingredients

- HALOBETASOL PROPIONATE: .5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-131"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-131
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c420da92-a3e3-4760-8cad-e50cbacebfeb